Suppr超能文献

肾细胞癌局限性肾切除术后晚期复发的结局和临床病理变量。

Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.

机构信息

Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Urology. 2011 Nov;78(5):1101-6. doi: 10.1016/j.urology.2011.05.012. Epub 2011 Sep 8.

Abstract

OBJECTIVE

To characterize the incidence and clinicopathologic factors associated with late recurrence after surgical resection for renal cell carcinoma (RCC) because the recurrence patterns >5 years after nephrectomy have been poorly described.

METHODS

We identified 1454 patients treated with nephrectomy for localized RCC from 1970 to 2000 who had remained free of disease for 5 years. Subsequent tumor recurrence was classified as renal recurrence and distant metastasis. The incidence of recurrence >5 years from surgery was estimated using the Kaplan-Meier method. The associations of clinicopathologic variables with late recurrence were analyzed using Cox proportional hazard regression models.

RESULTS

With a median postoperative follow-up of 13.9 years (range 5.1-38.9), 63 patients (4.3%) experienced late renal recurrence at a median of 9.3 years (range 5.1-25.3), and 172 patients (11.8%) developed late distant metastases at a median of 9.6 years (range 5.1-26.6) after surgery. The estimated recurrence-free survival rate at 10 and 15 years was 97.3% and 95.2% for renal recurrence, and 93.1% and 85.9% for distant metastases, respectively. On multivariate analysis, increased tumor size (hazard ratio [HR] 1.12; P < .001) was associated with late renal tumor recurrence, and increased tumor size (HR 1.07; P = .018), clear cell or collecting duct histologic features (HR 3.76; P < .001), and tumor Stage pT1b (HR 2.8; P < .001), pT2a (HR 4.5; P < .001), pT2b (HR 3.4; P = .007), and pT3-pT4 (HR 5.1; P < .001) were associated with distant metastasis.

CONCLUSION

After an initial 5-year postoperative disease-free interval, approximately 5% and 15% of patients will develop renal recurrence and distant metastases, respectively, during the next decade. Therefore, long-term surveillance remains necessary after nephrectomy.

摘要

目的

描述肾细胞癌(RCC)切除术后晚期复发的发生率和临床病理特征,因为术后 5 年以上的复发模式描述较差。

方法

我们从 1970 年至 2000 年期间,确定了 1454 例接受肾切除术治疗局限性 RCC 的患者,这些患者在 5 年内无疾病。随后的肿瘤复发分为肾复发和远处转移。使用 Kaplan-Meier 方法估计手术后 5 年以上的复发发生率。使用 Cox 比例风险回归模型分析临床病理变量与晚期复发的相关性。

结果

中位术后随访 13.9 年(范围 5.1-38.9),63 例(4.3%)患者在中位时间 9.3 年(范围 5.1-25.3)后出现晚期肾复发,172 例(11.8%)患者在中位时间 9.6 年(范围 5.1-26.6)后发生远处转移。10 年和 15 年的无复发生存率分别为肾复发的 97.3%和 95.2%,远处转移的 93.1%和 85.9%。多变量分析显示,肿瘤大小增加(风险比 [HR] 1.12;P<0.001)与晚期肾肿瘤复发相关,肿瘤大小增加(HR 1.07;P=0.018)、透明细胞或集合管组织学特征(HR 3.76;P<0.001)和肿瘤分期 pT1b(HR 2.8;P<0.001)、pT2a(HR 4.5;P<0.001)、pT2b(HR 3.4;P=0.007)和 pT3-pT4(HR 5.1;P<0.001)与远处转移相关。

结论

在最初的 5 年无病术后间隔后,接下来的 10 年内,大约 5%和 15%的患者将分别发生肾复发和远处转移。因此,肾切除术后仍需长期监测。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验